These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26091081)

  • 61. Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains.
    Kulkarni R; Arora R; Arora R; Chitambar SD
    Vaccine; 2014 Aug; 32 Suppl 1():A75-83. PubMed ID: 25091685
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain.
    Monnier N; Higo-Moriguchi K; Sun ZY; Prasad BV; Taniguchi K; Dormitzer PR
    J Virol; 2006 Feb; 80(3):1513-23. PubMed ID: 16415027
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
    Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine.
    Park WJ; Yoon YK; Park JS; Pansuriya R; Seok YJ; Ganapathy R
    Sci Rep; 2021 Nov; 11(1):22037. PubMed ID: 34764353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015-2016, with cogent genes of the Rotarix and RotaTeq vaccine strains.
    Morozova OV; Sashina TA; Epifanova NV; Zverev VV; Kashnikov AU; Novikova NA
    Virus Genes; 2018 Apr; 54(2):225-235. PubMed ID: 29236215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies.
    Tarr AW; Backx M; Hamed MR; Urbanowicz RA; McClure CP; Brown RJP; Ball JK
    Antiviral Res; 2018 Dec; 160():25-37. PubMed ID: 30217650
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.
    Larralde G; Li BG; Kapikian AZ; Gorziglia M
    J Virol; 1991 Jun; 65(6):3213-8. PubMed ID: 1709699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
    Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
    Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system.
    Bellido D; Craig PO; Mozgovoj MV; Gonzalez DD; Wigdorovitz A; Goldbaum FA; Dus Santos MJ
    Vaccine; 2009 Jan; 27(1):136-45. PubMed ID: 18973781
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Norovirus P particle, a novel platform for vaccine development and antibody production.
    Tan M; Huang P; Xia M; Fang PA; Zhong W; McNeal M; Wei C; Jiang W; Jiang X
    J Virol; 2011 Jan; 85(2):753-64. PubMed ID: 21068235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cloning and expression of human rotavirus spike protein, VP8*, in Escherichia coli.
    Kovacs-Nolan J; Sasaki E; Yoo D; Mine Y
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1183-8. PubMed ID: 11302740
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
    Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].
    Shao L; Fischer DD; Kandasamy S; Rauf A; Langel SN; Wentworth DE; Stucker KM; Halpin RA; Lam HC; Marthaler D; Saif LJ; Vlasova AN
    J Virol; 2016 Jan; 90(1):142-51. PubMed ID: 26468523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety, Immunogenicity, and Mechanism of a Rotavirus mRNA-LNP Vaccine in Mice.
    Lu C; Li Y; Chen R; Hu X; Leng Q; Song X; Lin X; Ye J; Wang J; Li J; Yao L; Tang X; Kuang X; Zhang G; Sun M; Zhou Y; Li H
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399987
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.
    Ramesh A; Mao J; Lei S; Twitchell E; Shiraz A; Jiang X; Tan M; Yuan AL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31698824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*.
    Yoo D; Lee J; Harland R; Gibbons E; Elazhary Y; Babiuk LA
    Adv Exp Med Biol; 1997; 412():405-11. PubMed ID: 9192047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.